Nathaniel Robinson, EVP and Chief Investment & Strategy Officer at Cushman & Wakefield Ltd. (NYSE:CWK), filed a Form 4 on September 10, 2026, disclosing the sale of 12,500 common shares on September 8, 2026.
Kristopher E. Moldovan, Executive Vice President and Chief Financial Officer of Vistra Corp. (NYSE:VST), filed a Form 4 on September 10, 2026, disclosing the sale of 20,000 shares of Vistra Corp. common stock on September 8, 2026, held indirectly through a family trust.
Director Kathy L. Hibbs of SOPHiA GENETICS SA filed a Form 4 on September 10, 2026, reporting the sale of 6,250 ordinary shares on September 8, 2026, pursuant to a Rule 10b5-1(c) trading plan.
Ryan Cohlhepp, President, COO and Interim CEO of Bicara Therapeutics Inc., filed a Form 4 on September 10, 2026, reporting stock option exercises and common stock sales that took place on September 8, 2026, pursuant to a Rule 10b5-1 trading plan.
Andrew Senn, President of Growth & Innovation at Integer Holdings Corp, filed a Form 4 with the SEC on September 10, 2026, reporting the sale of 9,408 shares of common stock on September 8, 2026.
David Ball, Executive Vice President and Chief Business Development Officer of Perrigo Company plc, filed a Form 4 on September 10, 2026, disclosing transactions in ordinary shares stemming from the vesting of Restricted Stock Units on September 9, 2026.
A Form 4 filed on September 10, 2026, reports that Sean Salmon, a director of Teleflex Incorporated (NYSE:TFX), received grants of restricted stock units and stock options on September 8, 2026.
A Form 4 filed with the SEC on September 10, 2026 discloses that Andrew Bliss, a director of Bullish (NASDAQ:BLSH), acquired 5,877 restricted share units on September 3, 2026 at no cost under the company's 2025 Omnibus Incentive Plan.
A Form 4 filed on September 10, 2026 discloses that Karen Jo Simon, a director of Bullish (NASDAQ:BLSH), was granted 5,877 restricted share units on September 3, 2026 under the company's 2025 Omnibus Incentive Plan.
Director Robert Gries Jr. filed a Form 4 with the SEC on September 10, 2026, disclosing two sales of Slide Insurance Holdings, Inc. common stock on September 8 and September 9, 2026, executed through GRM Family Limited Partnership pursuant to a Rule 10b5-1 trading …